IHH Healthcare faces near-term growth challenges in key markets despite long-term potential for ROA and valuation improvement. Learn why IHHHF stock is a hold.

Bharat Biotech to launch Hillchol, its oral cholera vaccine, amid a global shortage. With Phase III trials completed and 200M ...

Analysts say IHH's reputational harm claim in Japan won't impact Fortis's Indian operations; litigation continues over ...

IHH's Singapore-based indirect subsidiary Northern TK Ventures (NTK) has approached the Tokyo District Court seeking to amend ...

The lawsuit pertains to damages arising from the alleged obstruction by Daiichi of NTK’s efforts to acquire shares in Fortis ...

IHH Healthcare’s indirect subsidiary, NTK, has filed an application with the Tokyo District Court to increase its ongoing ...

IHH Healthcare said on Tuesday its unit has filed a petition in a Tokyo court to revise damages sought from Japan's Daiichi ...

Stay updated with Swisher Post! Read the latest news at Swisher Post.A tremor was felt in Midrand and Ekurhuleni on Tuesday ...

IHH Healthcare's indirect subsidiary, Northern TK Venture Pte Ltd, has significantly increased its damages claim against ...

IHH’s NTK arm raises damages claim to Rs 11,800 crore against Daiichi Sankyo, alleging obstruction in Fortis Healthcare ...

IHH Healthcare, supported by Mitsui, has increased its compensation claim against Daiichi Sankyo to $1.3 billion in the Tokyo ...